国立研究開発法人 国立成育医療研究センター National Center for Child Health and Development

代表: 03-3416-0181 / 予約センター(病院): 03-5494-7300
〈月~金曜日(祝祭日を除く)9時~17時〉

  • アクセス・交通案内
  • 予約センター
  • MENU
患者・ご家族の方へ Patient & Family
患者・ご家族の方へ Patient & Family

(業績 平成28年度)臓器移植センター

平成28年度

[英語原著論文:査読あり]

  1. Matsunami M,Shimozawa N,Fukuda A,Kumagai T,Kubota M,Chong PF,Kasahara M:Living-Donor Liver Transplantation From a Heterozygous Parent for Infantile Refsum Disease. Pediatrics, 2016;137(6)
  2. Ito K,Kasahara M,Saitoh A,Honda H,Miyairi I: High rate of vaccine failure after administration of acellular pertussis vaccine pre- and post-liver transplantation in children at a children's hospital in Japan. Transpl Infect Dis, 2016;18:150-4
  3. Matsunami M,Fukuda A,Sasaki K,Uchida H,Shigeta T,Hirata Y,Kanazawa H,Horikawa R,Nakazawa A,Suzuki T,Mizuta K,Kasahara M: Living donor domino liver transplantation using a maple syrup urine disease donor: A case series of three children-The first report from Japan. Pediatr Transplant, 2016;20(5):633-9.
  4. Umeshita K,Inomata Y,Furukawa H,Kasahara M,Kawasaki S,Kobayashi E,Kokudo N, Sakisaka S,Shimada M,Tanaka E, Uemoto S:Liver transplantation in Japan -Registry by the Japanese Liver Transplantation Society. Hepatol Res, 2016 ;46(12):1171-1186.
  5. Yoshizumi T,Takada Y,Shirabe K,Kaido T,Hidaka M,Honda M,Ito T,Shinoda M, Ohdan H,Kawagishi N,Sugawara Y,Ogura Y,Kasahara M,Kubo S,Taketomi A, Yamashita N,Uemoto S,Yamaue H,Miyazaki M,Takada T,Maehara Y: Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan. J Hepatobiliary Pancreat Sci, 2016;23(6):333-41
  6. Kanazawa H,Fukuda A,Mali VP,Rahayatri TH,Hirata Y,Sasaki K,Uchida H,Shigeta T, Sakamoto S,Matsumoto K,Kasahara M: Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation. Pediatr Transplant, 2016;20(3):401-7
  7. Yamaguchi M,Kataoka TR,Shibayama T,Fukuda A,Nakazawa A,Minamiguchi S, Sakurai T,Miyagawa-Hayashino A,Yorifuji T,Kasahara M,Uemoto S,Haga H: Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency. Pathol Int, 2016;66(6):333-6
  8. Baba C,Kasahara M,Kogure Y,Kasuya S,Ito S,Tamura T,Fukuda A,Horikawa R, Suzuki Y: Perioperative management of living-donor liver transplantation for methylmalonic academia. Paediatr Anaesth, 2016;26(7):694-702
  9. Uchida H,Fukuda A,Sasaki K,Hirata Y,Shigeta T,Kanazawa H,Nakazawa A, Miyazaki O,Nosaka S,Mali VP,Sakamoto S,Kasahara M: Benefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma. J Pediatr Surg, 2016;51(11):1807-1811
  10. Yasui T,Suzuki T,Hara F,Watanabe S,Uga N,Naoe A,Yoshikawa T,Ito T,Nakajima Y,Miura H,Sugioka A,Kato Y,Tokoro T,Tanahashi Y, Kasahara M,Fukuda A, Kurahashi H: Successful living donor liver transplantation for classical maple syrup urine disease. Pediatr Transplant, 2016;20(5):707-710
  11. Uchida H,Fukuda A,Sasaki K,Shigeta T,Hirata Y,Kanazawa H,Mali VP,Miyazaki O, Nosaka S, Sakamoto S,Kasahara M: Reno-and splenoportal anastomosis for a retransplant patient with situs inversus. Pediatr Transplant, 2016;20(4):594-596
  12. Geller J,Kasahara M,Martinez M,Soresina A,Kashanian F,Endrikat J: Safety and Efficacy of Gadoxetate Disodium-Enhanced Liver MRI in Pediatric Patients Aged >2 Months to <18 Years-Results of a Retrospective,Multicenter Study. Magn Reson Insights, 2016;21:9:21-8
  13. Furuichi M,Fujiwara T,Fukuda A,Kasahara M,Miyairi I: Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation. Transplantation, 2016;100(11):2404-2409
  14. Eguchi S,Furukawa H,Uemoto S,Umeshita K,Imamura H,Soyama A,Shimamura T, Isaji S,Ogura Y,Egawa H,Kawachi S,Kasahara M,Nagano H,Ku Y,Ohdan H,Maehara Y,Sato S,Inomata Y: Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey, Transplant Direct 2016;2(6):e74.
  15. Mali VP,Fukuda A,Shigeta T,Uchida H, Hirata Y,Rahayatri TH,Kanazawa H,Sasaki K,de Ville de Goyet J,Kasahara M: Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach. Pediatr Transplant, 2016;20(7):981-986
  16. Tsuboi N,Nozaki H,Ishida Y,Kanazawa I,Inamoto M,Hayashi K,Nishimura N, Nakagawa S,Kasahara M,Kamikubo T: Early Mobilization after Pediatric Liver Transplantation. Jornal of Pediatric Intensive Care, 2016
  17. Splinter K, Niemi AK, Cox R, Platt J, Shah M, Enns GM, Kasahara M, Bernstein JA: Impaired Health-Related Quality of Life in Children and Families Affected by Methylmalonic Acidemia. J Genet Couns, 2016;25(5):936-44 
  18. Sasaki A, Motomura K, Suyama F, Nagasawa J, Hisano M, Ito R, Miyazaki O, Nakazawa A, Ito Y, Kasahara M, Asai A, Matsumoto K, Sago H, Yamaguchi K:Fetal Magnetic Resonance Imaging Detection of Liver Iron Deposition in Neonatal Hemochromatosis During Prenatal Therapy. J Pediatr Gastroenterol Nutr, 2016;63(5):e121
  19. Furuichi M, Fujiwara T, Fukuda A, Kasahara M, Miyairi I:Fulminant Hepatic Failure as a Risk Factor for Cytomegalovirus Infection in Children Receiving Preemptive Therapy After Living Donor Liver Transplantation. Transplantation, 2016;100(11):2404-2409.
  20. Uchida H, Sakamoto S, Fukuda A, Sasaki K,Shigeta T, Nosaka S, Kubota M, Nakazawa A, Nakagawa S, Kasahara M:Sequential analysis of variable markers for predicting outcomes in pediatric patients with acute liver failure. Hepatol Res, 2016;10.1111

[日本語原著論文:査読あり]

  1. 齊藤 順平, 古市 宗弘, 徳永 秀美, 福田 晃也, 宮入 烈, 笠原 群生, 石川 洋一: 小児肝移植後サイトメガロウイルス(CMV)感染症のpre-emptive therapyにおけるCMV抗原陰性化日数に与える影響因子の検討,日本病院薬剤師会雑誌 2016;52(4) 401-405
  2. 齊藤 順平, 中河 秀憲, 小村 誠, 内田 孟, 福田 晃也, 宮入 烈, 笠原 群生, 石川 洋一:大量腹水・腎不全を併発した生体肝移植後サイトメガロウイルス感染に対し投与したガンシクロビルの血中・腹水中濃度測定を行った小児の1例,医学と薬学 2016;73(8)1025-1030
  3. [著書]

    (和文)

    1. ミトコンドリア学会,(協力者)笠原群生:ミトコンドリア病診療マニュアル2017. 2016/12/27

    [総説](学会など公共性のある機関からの依頼のもの、商業誌のぞく)

    1. 笠原群生: 【脳死肝移植の進展をいかに考えるべきか-脳死肝移植をもっと進展させなければ!-】 小児の肝移植を発展させよう 小児肝移植のさらなる進展に向けての提言. 肝胆膵 2016;72(3):489-495
    2. 笠原群生: 肝移植の適応と成績. 小児科臨床 69(11)2016 
    3. 馬場千晶, 小暮泰大, 糟谷周吾, 伊東祐之, 田村高子, 笠原群生, 鈴木康之:【大量出血の病態生理と輸血戦略】 肝臓移植術の大量出血 病態と戦略(ABO不適合移植における輸血ガイドライン含む). Thrombosis Medicine 2016;6(1)47-54
    4. 上野 義之, 橋本悦子, 笠原 群生, 伊藤鉄英:【肝胆膵の指定難病を整理する】 肝胆膵の指定難病を整理する. 肝・胆・膵 2016;72(4):749-760
    5. 成本壮一, 阪本靖介, 福田晃也, 笠原群生:【各臓器移植における長期成績とその問題点】 小児肝移植における長期成績とその問題点. 移植 2016;51(4-5):347-354
    6. 内田 孟, 阪本 靖介, 福田 晃也, 笠原 群生 :【知っておきたい小児外科疾患の最新の治療】 小児肝移植 現状と今後の展望.小児科臨床 2016;69(11):1787-1793